$266.28
3.27%
Nasdaq, Oct 09, 04:20 pm EDT. Closed.
Why the stock moved Why the stock moved Beta

Arm Target price 2026 - Analyst rating & recommendation

Arm Classifications & Recommendation

Buy
60%
Hold
36%
Sell
4%

Arm Price Target

Target Price $284.17
Price $266.28
Potential 6.72%
Number of Estimates 40
40 Analysts have issued a price target Arm 2027 . The average Arm target price is $284.17. This is 6.72% higher than the current stock price. The highest price target is $472.50 77.44% , the lowest is $126.25 52.59% .
A rating was issued by 45 analysts: 27 Analysts recommend Arm to buy, 16 to hold and 2 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Arm stock has an average upside potential 2027 of 6.72% . Most analysts recommend the Arm stock at Purchase.

Sales and Margin forecast 2027, 2028 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Mar '26 2027
Estimates
Revenue Billion $ 4.92 6.17
22.79% 25.33%
EBITDA Margin 20.43% 49.58%
10.64% 142.72%
Net Margin 18.37% 38.98%
7.04% 112.15%

45 Analysts have issued a sales forecast Arm 2027 . The average Arm sales estimate is

$6.2b
unlock
. This is
19.59% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$8.3b 60.42%
unlock
, the lowest is
$5.5b 6.54%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 $4.9b 22.79%
2027
$6.2b 25.33%
unlock
2028
$8.4b 35.70%
unlock
2029
$10.9b 30.37%
unlock
2030
$16.1b 47.27%
unlock
2031
$26.5b 65.20%
unlock
2032
$28.5b 7.48%
unlock
2033
$35.0b 22.74%
unlock

30 Analysts have issued an Arm EBITDA forecast 2027. The average Arm EBITDA estimate is

$3.1b
unlock
. This is
164.45% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$4.3b 275.61%
unlock
, the lowest is
$2.7b 136.94%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 $1.0b 9.72%
2027
$3.1b 204.18%
unlock
2028
$4.1b 34.41%
unlock
2029
$5.3b 29.20%
unlock
2030
$7.8b 46.56%
unlock
2031
$14.3b 84.10%
unlock

EBITDA Margin

2026 20.43% 10.64%
2027
49.58% 142.72%
unlock
2028
49.11% 0.95%
unlock
2029
48.67% 0.90%
unlock
2030
48.44% 0.47%
unlock
2031
53.98% 11.44%
unlock

45 Arm Analysts have issued a net profit forecast 2027. The average Arm net profit estimate is

$2.4b
unlock
. This is
130.20% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$2.7b 155.64%
unlock
, the lowest is
$2.2b 106.52%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 $904m 14.14%
2027
$2.4b 165.85%
unlock
2028
$3.3b 36.67%
unlock
2029
$4.4b 32.61%
unlock
2030
$6.6b 52.55%
unlock
2031
$11.2b 69.16%
unlock
2032
$12.9b 14.97%
unlock
2033
$15.4b 19.37%
unlock

Net Margin

2026 18.37% 7.04%
2027
38.98% 112.15%
unlock
2028
39.26% 0.72%
unlock
2029
39.93% 1.71%
unlock
2030
41.36% 3.58%
unlock
2031
42.36% 2.42%
unlock
2032
45.31% 6.96%
unlock
2033
44.06% 2.76%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 to 2033

Sign up for free to unlock analyst estimates. Sign up for free

Select at least one metric to display the chart.


Mar '26 2027
Estimates
Earnings Per Share $ 0.85 2.25
13.33% 164.71%
P/E 118.33
EV/Sales 47.06

45 Analysts have issued a Arm forecast for earnings per share. The average Arm EPS is

$2.25
unlock
. This is
131.96% higher
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
$2.50 157.73%
unlock
, the lowest is
$2.02 108.25%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 $0.85 13.33%
2027
$2.25 164.71%
unlock
2028
$3.08 36.89%
unlock
2029
$4.08 32.47%
unlock
2030
$6.22 52.45%
unlock
2031
$10.52 69.13%
unlock
2032
$12.10 15.02%
unlock
2033
$14.44 19.34%
unlock

P/E ratio

Current 274.52 18.70%
2027
118.33 56.89%
unlock
2028
86.58 26.83%
unlock
2029
65.29 24.59%
unlock
2030
42.80 34.45%
unlock
2031
25.30 40.89%
unlock
2032
22.01 13.00%
unlock
2033
18.44 16.22%
unlock

Based on analysts' sales estimates for 2027, the Arm stock is valued at an EV/Sales of

47.06
unlock
and an P/S ratio of
47.68
unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 56.27 46.54%
2027
47.06 16.38%
unlock
2028
34.68 26.31%
unlock
2029
26.60 23.29%
unlock
2030
18.06 32.10%
unlock
2031
10.93 39.47%
unlock
2032
10.17 6.96%
unlock
2033
8.29 18.53%
unlock

P/S ratio

Current 57.02 45.85%
2027
47.68 16.38%
unlock
2028
35.14 26.31%
unlock
2029
26.95 23.29%
unlock
2030
18.30 32.10%
unlock
2031
11.08 39.47%
unlock
2032
10.31 6.96%
unlock
2033
8.40 18.53%
unlock

Current Arm Upgrades & Downgrades

Analyst Rating Action Date
Rosenblatt
Buy
➜
Buy
Unchanged Jul 31 2026
TD Cowen
Buy
➜
Buy
Unchanged Jul 30 2026
Morgan Stanley
Equal-Weight
➜
Equal-Weight
Unchanged Jul 30 2026
Guggenheim
Buy
➜
Buy
Unchanged Jul 30 2026
RBC Capital
Outperform
➜
Outperform
Unchanged Jul 30 2026
UBS
Buy
➜
Buy
Unchanged Jul 30 2026
Needham
Buy
➜
Buy
Unchanged Jul 30 2026
Analyst Rating Date
Unchanged
Rosenblatt:
Buy
➜
Buy
Jul 31 2026
Unchanged
TD Cowen:
Buy
➜
Buy
Jul 30 2026
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
Jul 30 2026
Unchanged
Guggenheim:
Buy
➜
Buy
Jul 30 2026
Unchanged
RBC Capital:
Outperform
➜
Outperform
Jul 30 2026
Unchanged
UBS:
Buy
➜
Buy
Jul 30 2026
Unchanged
Needham:
Buy
➜
Buy
Jul 30 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today